Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 Nov 29:4:1446650.
doi: 10.3389/fruro.2024.1446650. eCollection 2024.

Giant prostatic hyperplasia in a 54-years old patient treated by prostate artery embolization: case report

Affiliations
Case Reports

Giant prostatic hyperplasia in a 54-years old patient treated by prostate artery embolization: case report

Nicolas Villard et al. Front Urol. .

Abstract

Giant prostatic hyperplasia (GPH) is defined as benign prostate hyperplasia (BPH) of more than 200 ml. It is a challenging condition because transurethral resection is classically indicated for prostate volume less than 80 ml and open adenectomy remains the gold standard therapy for GPH. Herein, we present the case of a 54-years old male with giant prostatic hyperplasia (total prostate volume of 265 ml) causing lower urinary tract symptoms (LUTS) and recurrent episodes of acute urinary retention. The patient refused the surgical adenomectomy and underwent bilateral prostate arteries embolization (PAE). Post embolization period was uneventful. Total prostate volume decreased progressively and LUTS disappeared. At more than 5 years follow-up the patient remains still asymptomatic, despite the discrete regrowth of the prostate detected on imaging. This case report suggests that PEA may be a good alternative to open surgery for patients with symptomatic GPH.

Keywords: endovascular procedures; interventional radiology; lower urinary tract symptoms; prostatic hyperplasia; therapeutic embolization; transurethral resection of prostate.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Transrectal ultrasound with sagittal (A) and axial (B) planes showing a volume of 265 mL.
Figure 2
Figure 2
Digital subtraction angiogram (DSA) with the microcatheter positioned in the right (A) and then in the left (B) prostatic artery, just before injection of microspheres.
Figure 3
Figure 3
MRI 4-days after PAE: T1 FS after injection of contrast medium shows subtotal devascularization of the transitional zone of the prostate on axial (A) and sagittal (B) planes.
Figure 4
Figure 4
Debimetry 3-years after PAE showing excellent values with a peak velocity of 40.8 mL/s.

Similar articles

References

    1. Holm A, Lindgren H, Bläckberg M, Augutis M, Jakobsson P, Tell M, et al. Patients’ perspective on prostatic artery embolization: A qualitative study. SAGE Open Med. (2021) 9:205031212110009. doi: 10.1177/20503121211000908 - DOI - PMC - PubMed
    1. Wang MQ, Guo LP, Zhang GD, Yuan K, Li K, Duan F, et al. Prostatic arterial embolization for the treatment of lower urinary tract symptoms due to large (>80 mL) benign prostatic hyperplasia: results of midterm follow-up from Chinese population. BMC Urol. (2015) 15:33. doi: 10.1186/s12894-015-0026-5 - DOI - PMC - PubMed
    1. EAU Guidelines . Edn. Presented at the EAU Annual Congress Paris April 2024. European Association of Urology; (2024) ISBN 978-94-92671-23-3. Available at: https://uroweb.org/guidelines/management-of-non-neurogenic-male-luts/cha....
    1. Somwaru AS, Metting S, Flisnik LM, Nellamattathil MG, Sharma A, Katabathina VS. Prostate artery embolization has long term efficacy for treatment of severe lower urinary tract symptoms from giant prostatic hyperplasia. BMC Urol. (2020) 20:153. doi: 10.1186/s12894-020-00726-y - DOI - PMC - PubMed
    1. Zhang J, Wang Y, Li S, Jin S, Zhang S, Zhao C, et al. Efficacy and safety evaluation of transurethral resection of the prostate versus plasmakinetic enucleation of the prostate in the treatment of massive benign prostatic hyperplasia. Urol Int. (2021) 105:735–42. doi: 10.1159/000511116 - DOI - PubMed

Publication types

LinkOut - more resources